A smart multifunctional drug delivery nanoplatform for targeting cancer cells.

Wirelessly guided magnetic nanomachines are promising vectors for targeted drug delivery, which have the potential to minimize the interaction between anticancer agents and healthy tissues. In this work, we propose a smart multifunctional drug delivery nanomachine for targeted drug delivery that incorporates a stimuli-responsive building block. The nanomachine consists of a magnetic nickel (Ni) nanotube that contains a pH-responsive chitosan hydrogel in its inner cavity. The chitosan inside the nanotube serves as a matrix that can selectively release drugs in acidic environments, such as the extracellular space of most tumors. Approximately a 2.5 times higher drug release from Ni nanotubes at pH = 6 is achieved compared to that at pH = 7.4. The outside of the Ni tube is coated with gold. A fluorescein isothiocyanate (FITC) labeled thiol-ssDNA, a biological marker, was conjugated on its surface by thiol-gold click chemistry, which enables traceability. The Ni nanotube allows the propulsion of the device by means of external magnetic fields. As the proposed nanoarchitecture integrates different functional building blocks, our drug delivery nanoplatform can be employed for carrying molecular drug conjugates and for performing targeted combinatorial therapies, which can provide an alternative and supplementary solution to current drug delivery technologies.

[1]  Chandra P. Sharma,et al.  Chitosan and Its Derivatives for Drug Delivery Perspective , 2011 .

[2]  Natalia L. Komarova,et al.  Cancer: Calculated treatment , 2013, Nature.

[3]  V. Pokharkar,et al.  Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note , 2006, AAPS PharmSciTech.

[4]  R. Mahato,et al.  Pharmaceutical perspectives of cancer therapeutics , 2009 .

[5]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[6]  Vincent M Rotello,et al.  Functionalized gold nanoparticles for drug delivery. , 2007, Nanomedicine.

[7]  M. Bermejo,et al.  Hydrogels: an interesting strategy for smart drug delivery. , 2013, Therapeutic delivery.

[8]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[9]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[10]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[12]  David J. Cappelleri,et al.  Controlling multiple microrobots: recent progress and future challenges , 2015 .

[13]  G. Schwartsmann,et al.  Natural products in anticancer therapy. , 2001, Current opinion in pharmacology.

[14]  T. Allen Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.

[15]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[16]  A. Salahudeen,et al.  Hypertension in cancer patients. , 2011, Texas Heart Institute journal.

[17]  K. B. Sutradhar,et al.  Nanotechnology in Cancer Drug Delivery and Selective Targeting , 2014 .

[18]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.

[19]  Ioannis K. Kaliakatsos,et al.  Microrobots for minimally invasive medicine. , 2010, Annual review of biomedical engineering.

[20]  Salvador Pané,et al.  Magnetoelectric micromachines with wirelessly controlled navigation and functionality , 2016 .

[21]  M. Ferrari Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[22]  G. Wondrak NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. , 2007, Free radical biology & medicine.

[23]  Shishir Shishodia,et al.  Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.

[24]  R. Tiwari,et al.  Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.

[25]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  P Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Dong Choon Hyun,et al.  Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.

[28]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[29]  K. Leong,et al.  Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles. , 2015, Nanoscale.

[30]  Martin Pumera,et al.  Fabrication of Micro/Nanoscale Motors. , 2015, Chemical reviews.

[31]  Chih-Kuang Chen,et al.  Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[32]  C. Hierold,et al.  Degradable Magnetic Composites for Minimally Invasive Interventions: Device Fabrication, Targeted Drug Delivery, and Cytotoxicity Tests , 2016, Advanced materials.

[33]  Arti Vashist,et al.  Recent advances in hydrogel based drug delivery systems for the human body. , 2014, Journal of materials chemistry. B.

[34]  S. Fusco,et al.  Chitosan Electrodeposition for Microrobotic Drug Delivery , 2013, Advanced healthcare materials.

[35]  R. Jayakumar,et al.  Chitosan for Biomaterials II , 2011 .

[36]  S. Cheng,et al.  Surface functionalized gold nanoparticles for drug delivery. , 2013, Journal of biomedical nanotechnology.

[37]  Adriele Prina-Mello,et al.  High content analysis of the biocompatibility of nickel nanowires , 2009 .

[38]  Salvador Pané,et al.  Magnetically Driven Silver‐Coated Nanocoils for Efficient Bacterial Contact Killing , 2016 .

[39]  A. Hopkins,et al.  The role of ligand efficiency metrics in drug discovery , 2014, Nature Reviews Drug Discovery.

[40]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[41]  Mark D Pagel,et al.  Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods. , 2015, Advances in radiology.

[42]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[43]  R. Hurt,et al.  Bioavailability, intracellular mobilization of nickel, and HIF-1α activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticles. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Jens Lienig,et al.  Review on Hydrogel-based pH Sensors and Microsensors , 2008, Sensors.

[45]  R. Reid,et al.  Hydrogel drug delivery system with predictable and tunable drug release and degradation rates , 2013, Proceedings of the National Academy of Sciences.

[46]  S. De Flora,et al.  Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention , 2010, Journal of the National Cancer Institute.

[47]  M. Serra,et al.  Nickel, cobalt and chromium-induced cytotoxicity and intracellular accumulation in human hacat keratinocytes. , 2001, Toxicology.

[48]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[49]  G. Lu,et al.  A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles , 2012 .

[50]  R. Thangam,et al.  pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells. , 2013, Colloids and surfaces. B, Biointerfaces.